Articles by admin

Mike Rugen became the CEO of Tengasco, Inc. (NYSEMKT:TGC) in 2013, and we think it’s a good time to look at the… …read more […]

Yahoo finance’s Anjalee Khemlani and Zack Guzman break down the latest surrounding Eli Lilly’s vaccine trial. …read more […]

(Bloomberg) — The world’s biggest exchange-traded fund is losing cash at a faster pace than any of its peers as investors seek lower fees amid a wave of cost cutting.Traders have yanked $33 billion from SPDR S&P 500 ETF Trust (SPY) so far this year, the most in the industry, according to data compiled by Bloomberg. While the exodus was concentrated in February and March, when the coronavirus pandemic roiled global markets, it put the $294 billion fund tracking the U.S. stock benchmark at odds with the broader equity ETF universe — which has lured $119 billion in 2020.As issuers …read more […]

(Bloomberg) — Callaway Golf Co. climbed as much as 8% after the Wall Street Journal reported that it was nearing a deal to buy the remainder of driving-range chain Topgolf Entertainment Group, providing the golf-club giant with a new source of growth.The deal would value closely held Topgolf at more than $2 billion and could be completed this week, the newspaper reported, citing unidentified people familiar with the matter. Callaway, the maker of Big Bertha drivers and other equipment, already owns 14% of Topgolf.Topgolf driving ranges — which feature food, drinks and kids’ games — are seen as a way …read more […]

(Bloomberg) — Exact Sciences Corp. said it will acquire Thrive Earlier Detection Corp. to gain technology for cancer screening in a deal worth as much as $2.15 billion.The cash and stock agreement will bring closely held Thrive’s CancerSeek technology to Exact Sciences, helping establish the Madison, Wisconsin-based company as a competitor in blood-based, multi-cancer screening, according to a statement. Exact Sciences jumped as much as 22% to $130, its highest since the shares began trading in 2001.Testing companies are increasingly developing liquid biopsies that sift through patients’ blood for early signs of tumors, hoping to help doctors begin treatment before …read more […]

The company has begun a rolling data submission from its vaccine candidate to UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for it to start its independent assessment of evidence as and when it becomes available. Moderna is among the frontrunners in the race to develop a vaccine for the new coronavirus, including Pfizer Inc, Johnson & Johnson and Astrazeneca – all in their late-stage trials, interim data from which are expected in the coming weeks. …read more […]

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […] …read more […]

The job cuts, which are on top of Chevron’s plan to cut 10%-15% of its workforce, come after the company promised to lower its operating expenses by $1 billion this year in the face of sharply lower energy demand. Most of the cuts will take place this year, Chevron said. Noble had about 2,300 employees at the end of last year. …read more […]

White Brook Capital recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 2.23% for the quarter (net of fees), underperforming their benchmark, the S&P 400 Index which returned 4.77% in the same quarter. You should check out White Brook Capital’s top 5 stock […] …read more […]

Navin Jacob – UBS Pharmaceuticals Analyst joins Yahoo Finance’s On The Move panel to deep dive into the latest pharmaceutical earnings reports.
…read more […]

(Bloomberg) — The White House on Tuesday appeared resigned to what most observers of the fiscal-stimulus negotiations had long concluded: there won’t be a pre-election package.“We’re confident that we can get something in the coming weeks,” White House spokeswoman Alyssa Farah said Tuesday. When pressed on Fox News about whether that means not this week, she said, “We’re hoping within weeks, I don’t want to get too ahead of any announcements.”The departure of U.S. senators from the Capitol for a pre-election break on Monday had already made the logistics for passing a bill by Election Day practically impossible.The failure of …read more […]

The negotiations were based on a price in the range of $131-$134 for each Tiffany share, against the previous price of $135. Tiffany last month sued the Louis Vuitton owner in a Delaware court, alleging that the French company had been stalling the deal and that it had improperly tried to renegotiate the deal. LVMH had countersued, alleging that the U.S. company has been mismanaged during the COVID-19 pandemic. …read more […]

Mike Bailey, Director of Research at FBB Capital Partners, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss what’s moving the markets following Tuesday’s opening bell. …read more […]

It’s down to the wire. The U.S. Presidential elections are only a week away, and with the polls showing Biden has an edge over President Trump, investors are preparing.Oppenheimer’s Chief Investment Strategist John Stoltzfus points out that last week, stocks churned as investors rebalanced their portfolios, rotating and adding additional exposure to value stocks “while others took profits in growth names that had previously run-up substantially ahead of what could be higher capital gains and other taxes next year,” in the event that the Democrats come out on top.Highlighting that the expectation of an effective COVID-19 vaccine is behind the …read more […]